. Kaplan-Meier survival curves for all-cause mortality by HbA1c and HbA1c target categories. Cumulative survival by Kaplan-Meier analysis by HbA1c categories (A), HbA1c categories plus use of agents causing hypoglycaemia (B), HbA1c target categories (C), and HbA1c target categories plus use of agents causing hypoglycaemia (D). Number (percentage) of deaths or HRs (95% CI) for mortality are shown for each category. HbA1c = haemoglobin A1c; HR = hazard ratio; CI = confidence interval; C1 = HbA1c <6.5%; C2 = HbA1c 6.5%-7.49%; C3 = HbA1c 7.5%-8.49%; C4 = HbA1c >8.5%; T1 = HbA1c ontarget (<0.5% below or above personalized goal); T2 = HbA1c below-target (>0.5% below personalized goal); T3 = HbA1c above-target (>0.5% above personalized goal); hypo-= patients not on agents causing hypoglycaemia; hypo+ = patients on agents causing hypoglycaemia.
. Distribution of study participants according to personalized HbA1c goals and target categories. All  T1  T2  T3  All  G0 3,859 (24.6) HbA1c = haemoglobin A1c; G0 = personalized HbA1c goal <6.5%; G1 = personalized HbA1c goal <7.0%; G2 = personalized HbA1c goal <7.5%; G3 = personalized HbA1c goal <8.0%; G4 = personalized HbA1c goal <8.5%; T1 = HbA1c on-target (<0.5% below or above personalized goal); T2 = HbA1c below-target (>0.5% below personalized goal); T3 = HbA1c above-target (>0.5% above personalized goal); hypo-= patients not on agents causing hypoglycaemia; hypo+ = patients on agents causing hypoglycaemia. <0.001 HbA1c = haemoglobin A1c; hypo-= patients not on agents causing hypoglycaemia; hypo+ = patients on agents causing hypoglycaemia; T1 = HbA1c on-target (<0.5% below or above personalized goal); T2 = HbA1c below-target (>0.5% below personalized goal); T3 = HbA1c above-target (>0.5% above personalized goal); BMI = body mass index; BP = blood pressure; ACE-I = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; eGFR = estimated glomerular filtration rate; DKD = diabetic kidney disease; DR = diabetic retinopathy; = CVD = cardiovascular disease; COPD = chronic obstructive pulmonary disease.
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